Location History:
- Le Plessis Robinson, FR (2012)
- Marseille, CH (2017)
- Fontenay-aux-Roses, FR (2018 - 2021)
Company Filing History:
4 out of 4,910 
2 out of 1,835 
2 out of 62 
Years Active: 2012-2021
Title: Nicole Deglon: Innovator in Alzheimer's Disease Research
Introduction
Nicole Deglon is a prominent inventor based in Fontenay-aux-Roses, France. She has made significant contributions to the field of medical research, particularly in the study of Alzheimer's disease. With a total of 4 patents to her name, her work has the potential to advance our understanding and treatment of this debilitating condition.
Latest Patents
One of her latest patents focuses on an Alzheimer's disease animal model. This invention relates to a vector that comprises a nucleic acid sequence encoding the APP protein and/or the PS1 protein or variants thereof. The invention also includes a method for inducing Alzheimer's disease in an animal using this vector, as well as an animal model that exhibits Alzheimer's disease obtained through this method. This innovative approach could pave the way for new research methodologies in the study of Alzheimer's disease.
Career Highlights
Throughout her career, Nicole has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to contribute to groundbreaking research and development in the medical field.
Collaborations
Nicole has collaborated with notable colleagues, including Nathalie Cartier-Lacave and Jerome Braudeau. These partnerships have further enriched her research endeavors and have fostered a collaborative environment for innovation.
Conclusion
Nicole Deglon's work in Alzheimer's disease research exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations highlight her commitment to advancing our understanding of this complex disease. Through her contributions, she continues to inspire future research and innovation in the realm of neuroscience.